Antimicrobial-resistant infections
Conference Coverage
New low-dose antibiotics, topicals offer options for acne
Video
VIDEO: Gut microbiota may predict C. diff treatment response
Gut microbiota may be an effective predictor of Clostridium difficile treatment response.
Conference Coverage
CHEST: Oral solithromycin shows pneumonia pivotal-trial efficacy
Solithromycin may offer a way to once again have a macrolide available for empiric oral treatment of more severe community-acquired pneumonia.
Conference Coverage
Experts debate fecal transplants as first-line therapy for CDI
Fecal microbiota transplantation is now first-line therapy for Clostridium difficile infection in much of Scandinavia – two specialists debated...
Conference Coverage
IDWEEK: Antibiotic ‘time-out’ cut vancomycin use
A self-directed antibiotic time-out performed 72-96 hours into treatment was tied to increases in appropriate discontinuations of vancomycin.
Conference Coverage
Some household pets found to be colonized with S. aureus
In households of children with methicillin-resistant Staphylococcus aureus (MRSA) infection, pet dogs and cats were often colonized with S. aureus...
News
Software picked up HAI clusters faster than hospitals
“The vast majority of hospitals were very pleased to expand surveillance beyond multidrug-resistant organisms, and most thought this system would...
News
Decline in antibiotic effectiveness could harm surgical, chemotherapy patients
An increase of surgical site infections stemming from pathogens resistant to antibiotic prophylaxis could result in thousands of infection-related...
News
Carbapenem resistance on the rise in children
The prevalence of carbapenem-resistant Enterobacteriaceae in children is low but has increased significantly since 1999, particularly among...
Conference Coverage
Hospitals report inadequate duodenoscope reprocessing practices
Less than a third of hospitals reprocessed duodenoscopes adequately to prevent potential transmission of carbapenem-resistant Enterobacteriaceae (...
Conference Coverage
Old drug is new treatment for chronic prostatitis
Oral fosfomycin achieved an 85% cure rate in multidrug-resistant chronic prostatitis.